140 related articles for article (PubMed ID: 11270908)
1. Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder.
Gladsjo JA; Rapaport MH; McKinney R; Auerbach M; Hahn T; Rabin A; Oliver T; Haze A; Judd LL
J Clin Psychopharmacol; 2001 Apr; 21(2):131-8. PubMed ID: 11270908
[TBL] [Abstract][Full Text] [Related]
2. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
Leufkens TR; Vermeeren A; Smink BE; van Ruitenbeek P; Ramaekers JG
Psychopharmacology (Berl); 2007 May; 191(4):951-9. PubMed ID: 17219217
[TBL] [Abstract][Full Text] [Related]
3. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
4. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
5. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
6. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam extended-release in panic disorder.
Rickels K
Expert Opin Pharmacother; 2004 Jul; 5(7):1599-611. PubMed ID: 15212610
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of alprazolam in the therapy of panic disorders].
Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
Pecknold J; Luthe L; Munjack D; Alexander P
J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
[TBL] [Abstract][Full Text] [Related]
12. Xanax XR for panic disorder.
Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
[No Abstract] [Full Text] [Related]
13. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
Verster JC; Volkerts ER; Verbaten MN
Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
[TBL] [Abstract][Full Text] [Related]
14. Efficacy studies of alprazolam in panic disorder.
Spiegel DA
Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
Fukuda M; Takazawa S; Nakagome K; Iwanami A; Hata A; Kasai K; Hiramatsu K
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
[TBL] [Abstract][Full Text] [Related]
16. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Verster JC; Volkerts ER
CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients.
Kiliç C; Curran HV; Noshirvani H; Marks IM; Başoğlu M
Psychol Med; 1999 Jan; 29(1):225-31. PubMed ID: 10077311
[TBL] [Abstract][Full Text] [Related]
19. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
Woods SW; Nagy LM; Koleszar AS; Krystal JH; Heninger GR; Charney DS
J Clin Psychopharmacol; 1992 Feb; 12(1):32-8. PubMed ID: 1552038
[TBL] [Abstract][Full Text] [Related]
20. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
